RCM & Prior Auth AI
A

Amperos

Amperos builds AI agents for insurance collections and denial management at healthcare providers. Its software follows claims across payer phone calls, online portals, explanations of benefits, appeals, and corrected submissions. Revenue cycle teams can assign the service selected claim categories or broader collection work, while experienced specialists and customer staff handle exceptions requiring judgment.

The current platform extends the Amanda agent's payer conversations and portal work into a wider collection workflow. Deployment teams configure payer priorities and operating procedures, and reporting shows how assigned claims progress. Connections to practice management systems return results to the organization's existing records rather than leaving call findings in a separate queue.

Named customers include Providence Anesthesia and Boulder Care. A September 2026 Providence case describes active claim work and writeback into Imagine during a practice management migration. Boulder uses the service for first-touch denials and accounts receivable follow-up in substance use treatment. These accounts describe operational capacity and collection economics, rather than clinical decision support.

Buyers include finance leaders, revenue cycle managers, and practice administrators at specialty groups, dental organizations, and telehealth providers. Commercial arrangements follow a demonstration and agreement. The public ROI calculator estimates possible operating benefits, while service pricing and the customer's final workflow scope require a quote.

AI Health Index verifiedOctober 14, 2026
Compare Amperos with other vendors
Founded
2023
Headquarters
New York, New York, United States
Categories
rcm-and-prior-auth
Indexed Products
Amperos insurance collections, Amanda AI agent
Buyer Segments
Specialty medical groups, Dental organizations, Telehealth providers, Revenue cycle teams
Assessment

Capability Axes

An AI Health Index grade measures what a buyer can verify from public sources on the date shown. It is not a rating of how good the product is. A vendor can build an excellent system and grade low on an axis because it publishes nothing an outsider can check. How grades read

AI Capability
AA on AI CentralityThe artificial intelligence is the product. Remove the model and there is nothing left to sell.
Vendor Published

AI agents perform the main collection tasks, combining payer conversations, portal navigation, document retrieval, appeals, and corrected claim submission. The service is designed to carry information between those steps rather than automate only a phone call. Revenue cycle specialists and customer staff contribute judgment on exceptions, while configured procedures guide routine work. This division of labor makes AI essential to the software's central capacity and workflow proposition.

The conventional reporting and implementation services support that proposition, but removing the agents would remove the primary automated claim handling function offered to healthcare organizations.

DD on Autonomy and Oversight ModelNo oversight structure is published. An absolute claim that the system does not err grades here too, because a buyer who believes it will not build the review step that would catch a failure.
Vendor Published

Customers can limit the service to chosen claim categories and supply operating procedures and payer priorities. Named deployments route exceptions to experienced customer staff, while revenue cycle specialists support complex work. These are meaningful boundaries on the assigned workflow. The current recovery page nevertheless promises that nothing slows collections, an unqualified reliability statement that exceeds the more limited operational controls described.

Detailed uncertainty thresholds, prohibited claim actions, and required approvals remain incomplete. The oversight model therefore includes human escalation while leaving the advertised limits of autonomous completion and error handling insufficiently reconciled.

BB on Model and Technology TransparencyThe approach or the suppliers are named without the version and update discipline behind them. Naming a supplier is the entry to this band both here and on Model Supply Chain Disclosure, which ask different questions of the same disclosure: who receives the data, and what produces the output.
Vendor Published

The platform uses large language models across voice and computer interaction to carry out collection workflows. Its processor list names OpenAI, Anthropic, Deepgram, and ElevenLabs, providing visibility into possible language and speech services. The current product also describes how payer conversations, portals, appeals, and resubmissions are combined.

Specific production model versions, task assignments among suppliers, training provenance, evaluation thresholds, and change approval practices remain unspecified. This establishes a recognizable technical approach and several suppliers, while leaving the relationship between a deployed release and its measured performance incomplete.

BB on Model Supply Chain DisclosureSubstantial partial disclosure, or a chain that is structurally short: an in house build, a cleared model that cannot be quietly swapped, or a deployment where the transfer does not occur at all. Naming the model provider exits the band below into this one; the axis rises from here on the completeness of the party list and on the terms that govern data once it arrives.
Vendor Published

The September 2026 processor list names OpenAI, Anthropic, Deepgram, and ElevenLabs alongside AWS, Azure, communications providers, and other service vendors. This identifies several organizations potentially involved in language inference, speech, hosting, and collection support. The list does not map every provider to a particular workflow or state whether all are active for each customer.

Supplier specific training restrictions, retention periods, processing regions, and downstream contractual obligations remain unspecified. It therefore provides useful partial visibility into the AI supply chain without establishing a complete, current account of how claim and conversation data pass through it.

BB on Clinical and Operational EvidenceNamed deployments with dated outcome figures and enough method to test them, or published research short of independent validation.
Vendor Published

The September 2026 Providence Anesthesia case reports a 69% lower cost per claim worked relative to an internal biller handling the same volume. Assigned volume increased 50% within two months of the expanded service going live. The case also identifies $12.8 million of accounts receivable worked, which is an inventory measure rather than cash recovered. This is a named, dated operational comparison with a defined cost metric.

Independent evaluation, detailed claim denominators, and comparable current outcomes across customers remain unspecified. The findings support the particular workflow and economic comparison described, without proving general recovery performance.

CC on AI Safety and PHI StewardshipGeneral assurances of privacy and security that do not answer the questions artificial intelligence raises: what is retained, what reaches a model, and what happens to it there.
Vendor Published

The privacy policy allows recording and transcription of conversations and treats those materials as nonpersonal once identifying information is removed. It then permits broad use and disclosure of that nonpersonal information. The policy does not define a healthcare deidentification method or establish a specific model training restriction.

Retention limits, deletion of downstream copies, technical safeguards against fabricated claim information, and AI safety incident procedures remain unspecified. Human specialists and customer escalation paths provide operational review, but they do not resolve the data reuse and lifecycle terms for recordings, transcripts, or generated claim documentation.

Regulatory and Compliance
CC on HIPAA and BAA PostureA status is stated but not supported: compliance is claimed, or business associate status stated, without the underlying document, including where the only privacy notice published covers the website rather than the service that handles patients. The mirror case grades here as well: a substantive privacy document that reaches the service, with no statement of business associate status anywhere and no scope position taken. One of the two elements the band above asks for is present, which is a grade below it and not a grade at the floor.
Vendor Published

The company claims HIPAA compliance, and its September 2026 privacy policy applies to both the website and back-office services. That policy names several processing providers and describes encryption and other safeguards. However, much of its personal information language concerns account details, communications, and general service use.

An accessible customer BAA, PHI specific contractual terms, subcontractor business associate obligations, and coverage of individual product or trial arrangements remain unspecified. The compliance claim and processor list therefore provide relevant context without establishing the complete contractual treatment of patient information used in collection work.

BB on Security Certifications and Trust CenterA recognized certification is named in the vendor own material without the artifact, or with a scope or renewal question the buyer has to raise. A recognized certification here is an audit of how the vendor operates security, such as SOC 2, HITRUST or ISO/IEC 27001. A certification has a scope and a clock, and both are part of this grade. A certification the vendor attaches to its data center, hosting facility or cloud provider, rather than presenting as its own, is the host's and does not count here.
Vendor Published

The company's own site carries an AICPA SOC assurance badge and HIPAA compliance monitoring language associated with Drata. These indicate an assurance claim, alongside privacy-policy descriptions of encryption, firewalls, and account protections. The audit type, auditor, reporting period, covered systems, and a current retrievable report remain unspecified.

The available claim therefore supports recognition of a security program without establishing the precise scope of its independent assessment. Compliance monitoring and technical controls also serve different purposes from an audit artifact and do not independently verify coverage of each AI provider.

CC on FDA and Regulatory StatusNo device claim is made and the product is scoped accordingly. Most administrative and operational products sit here and are not penalized for it, because this axis grades the appropriateness of the positioning rather than possession of a clearance.
Vendor Published

The current product works on insurance collections, denials, payer follow-up, appeals, and corrected claim submissions. Its outputs concern reimbursement administration and the provider's financial workflow rather than diagnosis, treatment selection, or direct patient monitoring. Clinical records may supply information for a claim without making the service a clinical decision tool. No FDA clearance is claimed for these administrative functions. The relevant product scope is therefore revenue cycle work, and the available descriptions do not establish a separate diagnostic or therapeutic intended use for the agents.

CC on AI Governance and Bias DisclosureResponsible artificial intelligence is committed to in policy language with no evaluation behind it. Most of the index sits here.
Vendor Published

Deployment teams translate customer procedures and payer priorities into operating rules, and specialists guide work that requires judgment. Reporting identifies collection trends and denial causes, giving customers a practical way to review workflow performance. These are operational controls rather than a defined framework for governing model behavior.

A current AI oversight structure, formal model release criteria, subgroup performance comparisons, and review materials for customer governance committees remain unspecified. Earlier customer advisory activity does not establish a current model governance process or evidence that outcomes are comparable across claim or patient populations.

BB on AI Liability and RecourseA published falsifiable commitment, or a real correction route the affected person can exercise against the vendor. A published error rate with its method and denominator grades here. A statutory right that runs to the covered entity rather than to the vendor does not reach this band on its own: every other route here asks something of the vendor, and being located in a particular jurisdiction is not conduct.
Vendor Published

The Standard Support Program is incorporated into customer subscription agreements and expressly covers errors and unexpected product behavior. It offers email and established shared-workspace channels, with target initial responses ranging from four business hours for critical service issues to two business days for ordinary issues. This is a concrete customer route for reporting and addressing problems. The targets concern response rather than guaranteed resolution or claim recovery.

Output specific indemnity, compensation for an incorrect action, and reimbursement for lost revenue remain unspecified. Website terms alone do not establish the allocation of liability in a customer's subscription agreement.

Integration and Deployment
AA on EHR and Interoperability DepthNamed bidirectional integrations with major record systems, verifiable in marketplace listings or integration documentation, with evidence the connection runs in production.
Vendor Published

The Providence Anesthesia deployment describes production work inside a named practice management workflow. Agents take assigned claims, call payers, navigate portals, retrieve explanations of benefits, submit appeals, and resubmit corrected claims. Actions write back into Imagine, while exceptions route to Providence's team. This links a named customer, named system, and actual operational read and write activity.

The Boulder case adds another production writeback example but leaves its system unnamed. General compatibility references elsewhere are therefore secondary to the concrete Imagine deployment; they do not independently establish the same depth for every listed platform.

CC on Deployment Model and Data ResidencyA single hosted option with location implied rather than committed.
Vendor Published

The service is delivered through a hosted processing stack, with AWS and Azure among the providers authorized to receive personal information. Customer systems connect to the claim workflow, and implementation teams configure procedures and integrations. These details identify hosting suppliers and operating setup without defining where each type of data is processed.

Exclusive residency, model inference regions, tenant isolation design, backup locations, and private deployment options remain unspecified. A US customer base or named cloud vendor alone does not establish a commitment that claim records and conversation data remain in a particular country.

Commercial
CC on Commercial TransparencyNo price is published and the posture is discoverable: a buyer can establish how the product is sold and what drives the cost before contacting the vendor. Most of the index sits here.
Vendor Published

Purchasing follows a demonstration and commercial agreement. The ROI calculator uses staffing costs, claims volume, average charges, backlog, and current collection rate to estimate potential benefits. Its displayed labor cost and collection-rate projection are inputs or estimates, not a subscription price. Current service fees, any percentage of collections, minimum commitments, and implementation charges remain unspecified. Customer savings stories explain possible value, but they do not establish the amount a buyer would owe for a particular assignment of claims.

BB on Setting and Specialty CoverageCoverage is named with validation behind part of it.
Vendor Published

Providence Anesthesia and Boulder Care provide named current deployments in anesthesia billing and substance use treatment. The former describes complex reimbursement during a practice management migration, while the latter uses the service for denials and follow-up in a telehealth organization. Additional named customers and specialty offerings span dermatology, eye care, orthopedics, dental care, and other provider groups. These references support several operational settings.

Comparable results by specialty, payer mix, or claim complexity remain unspecified, so one customer's recovery economics cannot establish expected performance for another group's billing rules and reimbursement conditions.

Commercial

Pricing

Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.

Entry Price Pricing Basis BAA Tier Implementation Source
Custom quote
Commercial agreement HIPAA compliance claimed; BAA coverage unspecified Not disclosed Vendor Published

No base price, fee percentage, or minimum commitment is specified. The calculator's $550,000 labor estimate and 97% collection estimate are illustrative operating inputs and projections, not vendor prices.